Skye Bioscience Stock (NASDAQ: SKYE) stock price, news, charts, stock research, profile.
Open | $13.000 |
Close | - |
Volume / Avg. | 20.515K / 42.324K |
Day Range | 12.800 - 13.200 |
52 Wk Range | 1.440 - 19.410 |
Market Cap | $449.007M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 0.21% |
Days to Cover | 1.42 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Skye Bioscience (NASDAQ: SKYE) through any online brokerage.
Other companies in Skye Bioscience’s space includes: Precigen (NASDAQ:PGEN), Replimune Group (NASDAQ:REPL), PepGen (NASDAQ:PEPG), Anika Therapeutics (NASDAQ:ANIK) and TScan Therapeutics (NASDAQ:TCRX).
The latest price target for Skye Bioscience (NASDAQ: SKYE) was reported by Oppenheimer on Friday, April 12, 2024. The analyst firm set a price target for 25.00 expecting SKYE to rise to within 12 months (a possible 56.25% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Skye Bioscience (NASDAQ: SKYE) is $16 last updated April 23, 2024 at 9:24 AM EDT.
There are no upcoming dividends for Skye Bioscience.
Skye Bioscience does not have any upcoming earnings scheduled.
There is no upcoming split for Skye Bioscience.
Skye Bioscience is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.